The efficacy of biologically active peptides derived from prostate tissue of bulls, in the treatment of excretory-toxic infertility, complication of chronic abacterial prostatitis

Authors

  • O. A. Nikiforov

DOI:

https://doi.org/10.14739/2310-1210.2014.5.29144

Keywords:

Infertility, Prostatitis, Therapy

Abstract

Aim. The paper discusses aspects of the etiopathogenesis of chronic abacterial prostatitis, results of the treatment of 126 patients with this pathology.

Methods and results. The patients were divided into II group. I group received usual therapy, group II – standard drugs plus group of biologically active peptides derived from prostate tissue of bulls that have reached sexual maturity. The results analysis shows that use of biologically active peptides derived from prostate tissue of bulls, the age of sexual maturity, allows to achieve the best results of treatment of patients with excretory-toxic infertility, that is complication of chronic abacterial prostatitis compared with the control group.

Conclusion. This new drug use helps to achieve a stable clinical effect and enhance the performance of the ejaculate.

References

Gorpinchenko, I. I., Gurzhenko, Yu. N., Klimenko, P. M., & Spiridonenko, V. V. (2010) Prakticheskij opyt kompleksnogo lecheniya bolnykh e`kskretorno-toksicheskim besplodiem [Practical experience in the complex treatment of patients with excretory-toxic infertility]. Novosti mediciny i farmacii, 18(341), Retrieved from: http://www.mif-ua.com/archive/article/14430. [in Ukrainian].

Gorpinchenko, I. I., Imshineckaya, L. P., Gurzhenko, Yu. N., Shulyak, A. V., Spiridonenko, V. V., & Lyubarskiy, A. V. (2009) E`kskretorno-toksicheskoe besplodie i ego kompleksnoe lechenie s ispolzovaniem preparata Ziman (rukovodstvo dlya prakticheskikh vrachej) [Excretory-toxic infertility and its complex treatment with the drug Ziman (a guide for practitioners)]. Kyiv. [in Ukrainian].

International Prostate Symptom Score (I-PSS) Retrieved

from: http://www.urospec.com/uro/Forms/ipss.pdf.

Gorpinchenko, I. I., & Gurzhenko, Yu. N. (2013) Ispol`zovanie suppozitoriev Vitaprost Plyus v kompleksnom lechenii bo`lnykh khronicheskim nespecificheskim prostatitom [The use of suppositories Vitaprost Plus in the complex treatment of patients with chronic nonspecific prostatitis]. Zdorov`e muzhchiny, 1(44), 93–97. [in Ukrainian].

Lytvynets, O. A. (2011) Efektyvnist vykorystannia preparatu Vitaprost Forte v likuvanni khvorykh na dobroiakisnu giperplaziyu peredmikhurovoyi zalozy [Efficiency drug Vitaprost Forte in the treatment of benign prostatic hyperplasia] Zdorov`e muzhchiny, 2, 143–144. [in Ukrainian].

Boyko, A. I., Sosnin, M. D., & Gubar, A. O. (2014) Novyj pogliad na zastosuvannia preparatu Vitaprost u pacientiv iz zakhvoriuvanniamy peredmikhurovoyi zalozy [A new look at the drug Vitaprost in patients with diseases of the prostate]. Urologiya, 1(11), 29–33. [in Russian].

Barry, M. J., Fowler, F. Jr., O’Leary, M. P., & Measurement Committee of the American Urological Association (1992). The American Urological Association symptom index for benign prostatic hyperplasia. J. Urol., 148, 1549–1557.

Cockett, A. T. K., Khoury, S., Aso, Y., et al. (1996) The third International Consultation on Benign Prostatic Hyperplasia (BPH). Proceedings.

Nickel, J. C., & Sorensen, R. (1996). Transurethral Microwave Thermotherapy for Nonbacterial Prostatitis: A Randomized Double-Blind Sham Controlled Study Using New Prostatitis Specific Assessment Questionnaires. The Journal of Urology, 155(6), 1950–1955.

Downloads

How to Cite

1.
Nikiforov OA. The efficacy of biologically active peptides derived from prostate tissue of bulls, in the treatment of excretory-toxic infertility, complication of chronic abacterial prostatitis. Zaporozhye Medical Journal [Internet]. 2014Oct.20 [cited 2024Nov.13];16(5). Available from: http://zmj.zsmu.edu.ua/article/view/29144

Issue

No. 5 (2014): Zaporozhye medical journal

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.  Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)